News

Latest news articles on stock market, cryptocurrency, business and finance from Stocktwits
S&P 500, Dow Drop As Elevated Oil Prices Stoke Inflation Fears Ahead Of Fed Meeting Next Week — AAPL, AXP, CART, UBER In Focus
Brent crude rose 3.1% to end the session at $116.72 a barrel, the highest level since April.
Stocktwits
Tesla Stock Lags Apple Because Of ‘Communications Problem,’ Says Investor Gary Black
Tesla stock has not moved in five years because of a lack of credibility stemming from “overpromise and hyped-up expectations,” Black said.
Stocktwits
Delivery Firm Instacart Reportedly Explores Sale Options With Uber, DoorDash As Potential Buyers
Delivery Firm Instacart Reportedly Explores Sale Options With Uber, DoorDash As Potential Buyers
Stocktwits
OpenAI Sued By Texas Attorney General Over Deceptive Practices And AI Chatbot Dangers
Texas Attorney General Ken Paxton has filed a lawsuit against OpenAI and Chief Executive Sam Altman.
Stocktwits
BMY Stock Falls 2% After Patient Death In Early Multiple Sclerosis CAR T Trial
The death of the patient with highly active relapsing MS occurred after the study’s data cutoff.
Stocktwits
TGTX Stock Bucks Broader Biotech Selloff As Multiple Sclerosis Therapy Shows Promising Early Results — Here’s What Investors Need To Know
The Phase 1 trial evaluated patients whose disabilities continued to worsen despite receiving other treatments.
Stocktwits
PHAT Stock Eyes Worst Day In Nearly Two Years After Generic Drug Maker Challenges Key Drug’s Exclusivity
Phathom said BDR Pharmaceuticals International Pvt. Ltd. filed suit in the U.S. District Court for the District of Columbia against the FDA and related federal defendants.
Stocktwits
This SpaceX Bear Flips To Being A Bull On The Firm's AI Developments, Sees 70% Stock Upside
PhillipCapital has flipped its stance on SpaceX from ‘sell’ to ‘buy’.
Stocktwits
Lockheed Martin’s Growth Potential ‘Not Priced Into The Stock,’ UBS Says — Analyst Sees About 15% Upside Potential In LMT Shares
According to The Fly, Citi raised its price target on Lockheed Martin to $706 from $691 and maintained a ‘Buy’ rating, citing increased confidence in accelerating momentum across its segments.
Stocktwits
Iovance’s Melanoma Therapy Shows Promising 4-Year Data – Retail Says Acquisition Imminent Before 2027-End
Phase 2 results showed an objective response rate of 62.5%.
Stocktwits
SKYD Stock Gets JPMorgan Upgrade: Analyst Sees Skydance Gaining Ground On Netflix, Disney With Warner Bros. Deal
JPMorgan said the acquisition presents Skydance with opportunities to improve content monetization and reduce costs.
Stocktwits
VZ, TMUS, T Stocks Face Valuation Pressure From SpaceX Wireless Push But Tower Operators Stand To Gain, Says Citi
The firm sees additional downside for established wireless carriers but views SpaceX's potential network expansion as a positive development for cell tower operators.
Stocktwits
American Express To Cut 5% Of Global Workforce; Raises 2026 EPS Outlook
American Express plans to eliminate approximately 5% of its global workforce as part of a restructuring initiative that included a $336 million charge and aims to improve organizational efficiency.
Stocktwits
USO Jumps To Over 11-Year High As Brent Tops $116, WTI Crosses $100 Amid Escalating Middle East Tensions
Brent crude futures reached a six-month high on Friday as attacks on Saudi Arabia and concerns over further Middle East escalation fueled fears of oil supply disruptions.
Stocktwits
Merck CEO Plays Down Cost Concerns Over Intismeran — ‘We Don't See Cost As A Limit To Access’
In an interview with CNBC, Merck CEO Rob Davis said the company is confident it can deliver Intismeran at scale.
Stocktwits
CRDO Stock Hits 6-Month Low After MaxLinear Targets Credo-Dominated Cable Market
During the company’s earnings call, MaxLinear CEO Kishore Seendripu said the company is targeting 20% to 30% of the 1.6T active electrical cable market over the next couple of years.
Stocktwits
P&G’s Q1 Results Draw Price-Target Hikes As Analysts Cite Stronger Underlying Performance
According to The Fly, Morgan Stanley raised its price target on P&G to $185 from $166, maintaining an ‘Overweight’ rating, and said recent brand interventions and reinvestment had “begun to bear fruit.”
Stocktwits
Apple Overtakes Nvidia As World's Most Valuable Company — iPhone Duo Hits Stores Amid Strong Demand
IDC expects Apple to capture 44% of the foldable smartphone market by value this year, as strong initial interest tests the company's ability to meet demand.
Stocktwits
Dan Ives Calls AI Sell-Off ‘SaaS Apocalypse 2.0,’ Says Oracle Is ‘In The Toughest Spot’
Ives said the industry is in year three of an eight to 10 year “Vegas Strip 1955”-type build out during an interview with Bloomberg.
Stocktwits
BE Stock Extends Selloff After Q3 Print, But Morgan Stanley Sees A Production Ramp Ahead
Morgan Stanley increased its shipment forecasts citing confidence in Bloom Energy’s ability to scale production and convert its demand pipeline.
Stocktwits
MRNA Stock: Citi Questions Whether Melanoma Vaccine’s Benefit Justifies Individualized Tumor Harvesting And Manufacturing
According to The Fly, multiple analysts commented on Moderna’s Phase 3 melanoma-vaccine data, with Bernstein describing the stock’s decline as a “sell the news event” and TD Cowen calling the leaked results “compelling” .
Stocktwits
WDC's Pricing-Driven Earnings Beat Divides Wall Street — Analysts Warn Rising Capex, Potential Supply Increases Could Pressure Valuations
Western Digital's December-quarter earnings guidance topped estimates, but analysts remain divided over whether strong hard disk drive pricing and elevated margins can persist.
Stocktwits
MU, SNDK, SKHY Stocks Bounce After Thursday’s Markdown, But Strategists Split: ‘Great Buying Opportunity’ Versus ‘The Kospi Has Peaked’
In an interview with CNBC, Strategas’ Chris Verrone said the semiconductor sell-off appeared technical rather than fundamental and could present a buying opportunity.
Stocktwits
EVAX Stock Heads For Best Week Since January 2025 As Cancer Vaccine Shows 89% Target Precision
The company’s experimental EVX-01 drug triggered an immune response in every patient in a Phase 2 trial.
Stocktwits
Cathie Wood's ARK Loads Up 38,110 Meta Shares Across 3 ETFs Despite Mounting AI Spending Concerns
ARK's purchases came as Meta stock fell nearly 7% on Thursday, with investors weighing strong advertising growth and early Muse adoption against rising AI infrastructure costs.
Stocktwits
Nasdaq, Dow, S&P 500 Futures Drop Premarket: NVDA, AMD, META, CRWV, MRNA, WDC, BE In Focus
Stocktwits retail sentiment for SPY and DIA was ‘extremely bearish,’ while it remained ‘bearish’ for QQQ.
Stocktwits
Stocktwits Wall Street Wrap: Analysts Turn Bullish On SpaceX, Tesla, But Netflix And Chipotle Face Fresh Downgrades Amid Growth Concerns
Wall Street analysts reviewed several major stocks after earnings reports and changes in companies’ business plans.
Stocktwits
Crown Castle, American Tower Stocks Catch A SpaceX Boost — Which Tower REIT Does Wall Street Favor?
SpaceX’s spectrum purchase could open new revenue opportunities for tower operators.
Stocktwits
Stocktwits Space Race Weekly: RKLB, VSAT Beat SPCX With Modest Gains — ASTS And PL Sink Deeper
SpaceX continued Tesla merger talks and is reportedly exploring access to 80,000 U.S. cellular sites for a potential nationwide wireless network.
Stocktwits
'Big Short' Investor Michael Burry Bumps Up Substack Subscription Price, Flags 4 'Busted' Bear-Market Havens
Burry’s Substack annual revenue potential could reach $232.2 million, more than double July’s estimate.
Stocktwits

Advertisement|Remove ads.